Evolution of anti-SARS-CoV-2 spike protein titers after two-dose of COVID-19 vaccination among people living with HIV

• المؤلفون الرئيسيون: Wang-Da Liu (مؤلف), Man Wai Pang (مؤلف), Jann-Tay Wang (مؤلف), Hsin-Yun Sun (مؤلف), Yu-Shan Huang (مؤلف), Kuan-Yin Lin (مؤلف), Un-In Wu (مؤلف), Guei-Chi Li (مؤلف), Wen-Chun Liu (مؤلف), Yi-Ching Su (مؤلف), Pu-Chi He (مؤلف), Chia-Yi Lin (مؤلف), Chih-Yu Yeh (مؤلف), Yu-Chen Cheng (مؤلف), Yi Yao (مؤلف), Yi-Ting Chen (مؤلف), Pei-Ying Wu (مؤلف), Ling-Ya Chen (مؤلف), Yu-Zhen Luo (مؤلف), Hsi-Yen Chang (مؤلف), Wang-Huei Sheng (مؤلف), Szu-Min Hsieh (مؤلف), Sui-Yuan Chang (مؤلف), Chien-Ching Hung (مؤلف), Shan-Chwen Chang (مؤلف)
• التنسيق: كتاب
• منشور في: Elsevier, 2022-12-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Background: A community COVID-19 outbreak caused by the B.1.1.7 SARS-CoV-2 variant occurred in Taiwan in May 2021. High-risk populations such as people living with HIV (PLWH) were recommended to receive two doses of COVID-19 vaccines. While SARS-CoV-2 vaccines have demonstrated promising results in...